Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Quentin30 is Mattstafford9 on Stocktwits

<< Previous

Bullboard Posts

Next >>

Comment by Azzak34on Mar 27, 2024 3:26pm

68 Views

Post# 35956310

RE:RE:Quentin30 is Mattstafford9 on Stocktwits

What IS i smoking? It's a blueberry bubble thing, tastes great. Ohm brew is the brand, try it.

Ah Quenty I was worried you'd left us! Did you just Google a load of stocks that are up and claim to own them?

And stop telling porky pies, you mentioned crispr about 3 months ago and it's up about 6%.

Name your trades right now bro so we can all check them in real time bro.

<< Previous

Bullboard Posts

Next >>

Multi-bagger industrial stock adds $90M in new contracts